Legal analysis: COVID-19 vaccine residents are vaccinated free of charge by the National Medical Insurance Bureau; COVID-19 vaccine and vaccination costs are borne by the medical insurance fund, with appropriate financial subsidies. On the morning of February 20th, the State Council held a routine briefing on the the State Council policy of the Regulations on the Supervision and Administration of the Use of Medical Insurance Funds. At the meeting, Shi, deputy director of the National Medical Insurance Bureau, said in response to vaccination and other issues that the current round of vaccine and vaccination cost policies have been clarified: First, the vaccine and vaccination costs are borne by the medical insurance fund, and the financial sector gives appropriate subsidies to the medical insurance fund, and individual residents are vaccinated free of charge. Second, the medical insurance fund is mainly borne by the balance over the years, which does not affect the income and expenditure of the fund in the current period, that is to say, it will not affect the medical treatment of the people in the current period. Regarding the accumulated balance of the medical insurance fund, Shi said that according to the statistical express, the total income of the fund in 2020 was 2.4 trillion yuan, and the expenditure was about 2. 1 trillion yuan. The balance in that year was 270 billion, and the accumulated balance over the years exceeded 3 trillion. At present, the overall operation of the fund is stable and the balance is generally abundant. The use of the balance will not affect the people's current medical insurance benefits. "In the next step, we will carefully analyze the operation of the medical insurance fund and actively strengthen the supervision and management of the use of the medical insurance fund with relevant departments to ensure the long-term sustained and balanced operation of the fund." Shi stressed that on the whole, it is no problem for the medical insurance fund to bear the cost of vaccines and vaccinations.

Legal basis: People's Republic of China (PRC) Vaccine Management Law.

Forty-first the State Council health authorities to develop a national immunization program; The types of vaccines under the National Immunization Program shall be drawn up by the competent health department of the State Council in conjunction with the financial department of the State Council, and published after being approved by the State Council.

The health authorities in the State Council set up an expert advisory committee of the National Immunization Program, and established a dynamic adjustment mechanism for vaccine types of the National Immunization Program in conjunction with the financial department of the State Council.

The people's governments of provinces, autonomous regions and municipalities directly under the Central Government may, when implementing the national immunization program, increase the types of immunization program vaccines according to the needs of disease prevention and control in their respective administrative areas, and report them to the health authorities in the State Council for the record and publication.

Forty-second the State Council health authorities should formulate and publish vaccination work norms, and strengthen the standardized management of vaccination.

The health authorities in the State Council shall formulate and publish the immunization procedures of the national immunization program vaccine and the guiding principles for the use of non-immunization program vaccines.

The health authorities of the people's governments of provinces, autonomous regions and municipalities directly under the Central Government shall formulate vaccination plans in light of the actual conditions of their respective administrative regions and report them to the health authorities of the State Council for the record.

Forty-third disease prevention and control institutions at all levels shall, according to their respective responsibilities, carry out publicity, training, technical guidance, monitoring, evaluation, epidemiological investigation and emergency response related to vaccination.